DEFA14A ·Filed Mar 16, 2026
Proxy solicitation materials
Actionable Insight • Neutral
Monitor for the full proxy statement which may contain information about executive compensation, board elections, or shareholder proposals that could impact governance and investor sentiment
MRNA drugs
MRNA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60Entry
$53.82
T+0 close · Mar 16, 2026 · via day close
Latest settled
−11.32%
T+60 · $47.73
Vs SPY
−21.18%
α at T+60
Horizons
All settled
through T+60
- T+0 · Mar 17 $53.82entry
- T+1 · 8mo ago −2.68%α −1.28% · $52.38
- T+5 · 8mo ago −4.72%α −2.06% · $51.28
- T+20 · 7mo ago +0.72%α −3.58% · $54.21
- T+60 · 5mo ago −11.32%α −21.18% · $47.73
Price Chart
REPLAYWatch the reaction play outLoading chart...
How similar events traded
Executive Summary
Analysis based on filing metadata only, document content was unavailable
Key Facts
- Filing is a DEFA14A, which is a definitive additional proxy soliciting materials filing
- Filed by the registrant (Moderna, Inc.)
- No financial data or material business developments are visible in the available document headers
Financial Impact
No financial impact data available
Risk Factors
- Limited information available from this filing alone
- Potential for material shareholder proposals or governance changes not visible in this filing
Market Snapshot
Exchange
Nasdaq
Analyst Consensus
10% bullish (30 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001308179-26-000083 |
| Document: 0001308179-26-000083-index-headers.html | 0001308179-26-000083 |
| Document: 0001308179-26-000083-index.html | 0001308179-26-000083 |
| Document: 0001308179-26-000083.txt | 0001308179-26-000083 |
Track record
26 reports on MRNA
6 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +14.15% at T+60 after the Mar 5, 2026 report. 7 of 8 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 3/10 Entry $217.29 Now $215.27 −0.93% settles Nov 17
- Nov 13, 20263d ago 8-K Neutral 3/10 Entry $222.50 Now $215.27 −3.25% settles Nov 17
- Nov 6, 202610d ago 8-K Bullish 7/10 Entry $254.19 to $269.00 Now $215.27 −15.31% ▲ +5.83% +3.46% vs SPY
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $241.46 to $254.19 Now $215.27 −10.85% ▲ +5.27% +4.96% vs SPY
- Oct 28, 202619d ago Institutional Cluster Neutral 3/10 Entry $214.17 to $222.76 Now $215.27 +0.52% ▲ +4.01% +4.40% vs SPY
- Oct 27, 202620d ago ANALYST-DOWNGRADE Bearish 4/10 Entry $207.97 to $214.17 Now $215.27 −3.51% ▼ −2.98% −2.63% vs SPY
- Sep 30, 20266w ago 8-K Neutral 3/10 Entry $192.57 to $188.94 Now $215.27 +11.79% ▼ −1.89% −2.06% vs SPY
- Sep 30, 20266w ago ANALYST-DOWNGRADE Bearish 4/10 No price data
- Sep 16, 20268w ago Insider Cluster Bearish 5/10 Entry $158.07 to $154.04 Now $215.27 −36.19% ▲ +2.55% +2.43% vs SPY
- Sep 3, 202610w ago ANALYST-DOWNGRADE Bearish 6/10 Entry $148.87 to $145.55 Now $215.27 −44.60% ▲ +2.23% +1.84% vs SPY
Showing 10 of 26
US Market Status
Market Closed · Opens in 6h 26m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers